|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
1UG3CA211415-01
|
$375,888
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
|
1R01CA213131-01
|
$428,441
|
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
1R01CA213138-01
|
$395,738
|
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Personalized vaccine for patients with AML
|
1R01CA212649-01
|
$739,429
|
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Complex Role of HSF1 in Breast Cancer
|
5R01CA176326-04
|
$355,719
|
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-07
|
$465,791
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cooperation of Hippo/Yap and Hedgehog Pathways in BCC Development
|
5F32CA192815-03
|
$59,166
|
|
MAGLIC, DEJAN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor
|
1R01CA211646-01
|
$415,154
|
|
ZETTER, BRUCE
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cancer biology in the zebrafish
|
5R01CA103846-15
|
$373,081
|
|
ZON, LEONARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Impaired Glycosylation of Vascular Endothelial Growth Factor Receptor 2 in Tumor Angiogenesis
|
5F32CA196157-03
|
$59,166
|
|
CHANDLER, KEVIN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-06
|
$220,860
|
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Functional Effects of Ovarian Cancer Risk Variants
|
1R01CA211707-01
|
$686,463
|
|
GAYTHER, SIMON
|
CEDARS-SINAI MEDICAL CENTER
|
|
Microenvironment-Leukemia Communication Through Lectins
|
5R01CA172040-05
|
$336,150
|
|
HEISTERKAMP, NORA
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Crosstalk Between Platelets and Brain Tumor Initiating Cells in Glioblastoma
|
5F31CA196041-03
|
$44,044
|
|
LEE, CHRISTINE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
1R01CA211681-01
|
$504,721
|
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
Support of carcinoma metastasis by integrin a6-CD151-PKC complexes
|
5R01CA042368-31
|
$328,700
|
|
HEMLER, MARTIN
|
DANA-FARBER CANCER INST
|
|
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
|
1UG3CA211232-01
|
$399,986
|
|
CHILKOTI, ASHUTOSH
|
DUKE UNIVERSITY
|
|
Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas
|
1R01CA200808-01A1
|
$359,205
|
|
SOHER, BRIAN
|
DUKE UNIVERSITY
|
|
ECOG-ACRIN-Based QIN Resource for Advancing Quantitative Cancer Imaging in Clinical Trials
|
5U01CA190254-03
|
$635,273
|
|
SCHNALL, MITCHELL
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
|
1R01CA211996-01
|
$742,626
|
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-05
|
$151,059
|
$75,530
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer
|
5R01CA188341-03
|
$396,219
|
|
HOUGHTON, A
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
|
1R01CA213130-01
|
$767,849
|
|
MADELEINE, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
5R01CA169345-05
|
$322,663
|
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Mechanisms of p53 activation during stress response (MPI)
|
5R01CA141244-08
|
$376,591
|
|
CHEN, JIANDONG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
|
5U01CA172320-05
|
$485,638
|
|
TAOULI, BACHIR
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Evaluation of Implementation of Point-of-Care Palliative Care Quality Measures
|
5R21CA197362-02
|
$176,175
|
|
DY, SYDNEY
|
JOHNS HOPKINS UNIVERSITY
|
|
Facile screening for esophageal cancer in LMICs
|
1UG3CA211457-01
|
$430,285
|
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Role of TOP2B in generating complex genomic rearrangements in human cancer
|
5R01CA183965-04
|
$336,150
|
|
YEGNASUBRAMANIAN, SRINIVASAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Group Health Cancer Research Program Research Specialist Award
|
1R50CA211115-01
|
$75,679
|
|
BOWLES, ERIN
|
KAISER FOUNDATION HEALTH PLAN OF WASHINGTON
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$824
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Evaluation of metastatic brain tumor heterogeneity and physiological response to immunotherapy using advanced MRI
|
1R01CA211238-01
|
$108,103
|
|
GERSTNER, ELIZABETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas
|
5R01CA193520-02
|
$377,034
|
|
KLIBANSKI, ANNE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A prospective, multi-center pivotal study of the LUM Imaging System for real-time, in vivo margin assessment in breast conserving surgery
|
1R01CA212138-01
|
$723,579
|
|
SMITH, BARBARA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-22
|
$289,175
|
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR
|
5R01CA200551-02
|
$247,249
|
|
PARK, SEAN
|
MAYO CLINIC ROCHESTER
|
|
Molecular signature of inflammation
|
5R01CA179363-04
|
$321,921
|
|
MALARKANNAN, SUBRAMANIAM
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Elucidating the role of CD26 in T cell-mediated tumor immunity
|
5F31CA192787-03
|
$44,044
|
|
BAILEY, STEFANIE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis
|
5R01CA188305-03
|
$338,538
|
|
XIAO, HUA
|
MICHIGAN STATE UNIVERSITY
|
|
Anakinra for neutrophilic pustular skin disease
|
ZIA BC 011550
|
$254,713
|
$25,471
|
Cowen, Edward
|
CCR (NCI)
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 - 04180
|
$1,119,312
|
$22,386
|
Linet, Martha
|
DCEG (NCI)
|
|
Dosimetry for Nuclear Medicine Technologists
|
ZIA CP010133 - 10558
|
$113,182
|
$5,659
|
Linet, Martha
|
DCEG (NCI)
|
|
Cellular Interactions with Thrombospondin
|
ZIA SC 009172
|
$628,594
|
$31,430
|
Roberts, David
|
CCR (NCI)
|
|
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
|
ZIC BC 010953
|
$954,766
|
$47,738
|
Simpson, R. Mark
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$501,603
|
$150,481
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Redox Mechanism Process of Angiogenesis and Wound Healing
|
ZIA BC 010898
|
$212,128
|
$42,426
|
Wink, David
|
CCR (NCI)
|
|
Inflammation and cancer treatment
|
ZIA BC 010899
|
$424,256
|
$42,426
|
Wink, David
|
CCR (NCI)
|
|
Chemical Biology of Nitroxyl (HNO)
|
ZIA BC 011190
|
$106,064
|
$42,426
|
Wink, David
|
CCR (NCI)
|
|
Nitric Oxide as a Modifier of Oxidative Stress
|
ZIA SC 007281
|
$318,192
|
$63,638
|
Wink, David
|
CCR (NCI)
|
|
Communicate and LEarn About youR Variant of Uncertain Significance (CLEAR VUS)
|
5R03CA194643-02
|
$83,085
|
|
SCHERR, COURTNEY
|
NORTHWESTERN UNIVERSITY
|
Total relevant funding to Heart for this search: $1,404,791
|